Prolonged Invasive Ventilation Following Acute Ventilatory Failure in COPD* Weaning Results, Survival, and the Role of Noninvasive Ventilation
|
|
- Clemence O’Brien’
- 6 years ago
- Views:
Transcription
1 CHEST Prolonged Invasive Ventilation Following Acute Ventilatory Failure in COPD* Weaning Results, Survival, and the Role of Noninvasive Ventilation Timothy G. Quinnell, MRCP; Samantha Pilsworth, BSc; John M. Shneerson, MA, DM; and Ian E. Smith, MA, MD Original Research ACUTE VENTILATORY FAILURE Background: Invasive ventilation for COPD has significant mortality, and weaning can be difficult. At Papworth Hospital, we provide a specialist weaning service using noninvasive ventilation (NIV) for patients requiring prolonged invasive ventilation after recovery from acute illness. We analyzed our results for patients with COPD to identify factors associated with weaning outcome and survival. Methods: A retrospective analysis was conducted of COPD patients admitted for weaning from invasive ventilation, from 1992 to Weaning success and survival were assessed. Associations were sought between these outcomes and age, sex, spirometry, arterial blood gas levels, APACHE (acute physiology and chronic health evaluation) II score, length of stay (LOS), and the use of NIV and long-term oxygen therapy. Results: Sixty-seven patients were identified, all of whom were receiving tracheostomy ventilation on transfer to the Respiratory Support and Sleep Centre (RSSC). Sixty-four patients (95.5%) were weaned, and 62 patients survived to hospital discharge. NIV was used in weaning 40 patients and in the long term in 25 patients. Median survival was 2.5 years (interquartile range, 0.7 to 4.6 years). One-year, 2-year, and 5-year survival rates were 68%, 54%, and 25%, respectively. Long-term survival was inversely associated with age and LOS in the ICU and the RSSC. The provision of maintenance NIV after weaning was associated with better long-term survival, independent of age and LOS (hazard rate, 0.48; p 0.03). Conclusions: These results demonstrate that a specialist multidisciplinary approach, including the use of NIV, can be successful in weaning most COPD patients from prolonged invasive ventilation. The data also suggest that long-term NIV may improve survival in selected patients. (CHEST 2006; 129: ) Key words: COPD; invasive mechanical ventilation; noninvasive ventilation; tracheostomy; weaning Abbreviations: ABG arterial blood gas; APACHE acute physiology and chronic health evaluation; CI confidence interval; IMV invasive mechanical ventilation; IQR interquartile range; LOS length of stay; LTOT long-term oxygen therapy; NIV noninvasive ventilation; PCP Progressive Care Programme; PSV pressure support ventilation; Ptco 2 transcutaneous Pco 2 ; RSSC Respiratory Support and Sleep Centre; USB unsupported spontaneous breathing Acute ventilatory failure is common in exacerbations of COPD that require hospital admission. Despite the advent of noninvasive ventilation (NIV), *From Papworth Hospital, Papworth Everard, Cambridge, UK. Manuscript received February 2, 2005; revision accepted June 22, Reproduction of this article is prohibited without written permission from the American College of Chest Physicians ( org/misc/reprints.shtml). invasive mechanical ventilation (IMV) is still required by 15 to 26% of patients. 1,2 The prognosis for COPD patients requiring IMV for ventilatory failure is better than for those intubated for other reasons, 3 5 but hospital survival ranges from 76% to as low as 31%. 3,4,6 9 The pro- Correspondence to: Tim Quinnell, MRCP, Respiratory Support and Sleep Centre, Papworth Hospital, Papworth Everard, Cambridge, UK CB3 8RE; Tim.Quinnell@papworth.nhs.uk CHEST / 129 / 1/ JANUARY,
2 portion of ventilation time spent weaning is greater for COPD than for many other conditions. 10 In series 6,11 describing patients requiring prolonged IMV, 46 to 59% have had COPD. One-year survival for patients requiring IMV ranges from 57 to only 15%. 3,4,6 9 The Respiratory Support and Sleep Centre (RSSC) at Papworth Hospital, Cambridge offers a specialist weaning service for patients requiring prolonged IMV at other hospitals. This Progressive Care Programme (PCP) has been reported previously 12 and is applied by a multidisciplinary team with the goal of achieving independence from IMV. In this article, we present outcomes for COPD patients entered into the PCP from 1992 to 2003, we identify factors associated with weaning outcome and survival, and we discuss those aspects of our weaning strategy that may have contributed to the results achieved. Materials and Methods Patients are referred to the PCP when weaning has failed at the referring ICU. Those accepted for transfer to the RSSC have recovered from the acute illness that precipitated their intubation. Most receive ventilation via tracheostomy and are hemodynamically stable without need of inotropic support. General Care Following transfer to our unit, sedating drugs are withdrawn at the first opportunity, and a normal diurnal routine is reinforced. Respiratory function is optimized with bronchodilators and corticosteroids as indicated. Respiratory tract secretions are actively managed with physiotherapy, tracheal suctioning, and the appropriate use of antibiotics. The management of coexisting medical problems is reviewed, and metabolic abnormalities are corrected. Tube enteral feeding is used to optimize nutritional status, and a normal diet and supplements are introduced when swallowing is safe. Weaning from IMV On arrival, IMV is continued, using pressure support ventilation (PSV) with positive end-expiratory pressure aiming to normalize arterial blood gas (ABG) levels. Ventilatory weaning involves the introduction of unsupported spontaneous breathing (USB). Initial brief episodes (up to 30 min) are lengthened according to individual patient progress. This is guided by close clinical observation for respiratory distress, and the use of pulse oximetry, transcutaneous Pco 2 (Ptco 2 ) monitoring, and ABG levels. If, despite optimizing other medical therapies, the patient fails to increase the duration of USB without respiratory distress or hypercapnia (Paco 2 or Ptco kpa), then NIV is introduced (NIPPY 2 ventilator; B&D Electromedical; Stratford-on- Avon, UK). This is applied via a nasal or full-face mask with the tracheostomy tube capped off and its cuff deflated. NIV is guided by continuous oximetry and Ptco 2, and daytime ABG levels, aiming for normalization of Paco 2. For COPD patients, inspiratory pressure is titrated to a maximum of 36 cm H 2 O and expiratory pressure up to 6 cm H 2 O. Only when USB is effective for most of the day is IMV withdrawn at night. The provision of nocturnal NIV is determined by the same criteria guiding its daytime introduction (ie, respiratory distress and/or hypercapnia 7.5 kpa during USB). Oxygen is only prescribed for nocturnal use if the mean sleeping oxygen saturation drops below 80% and NIV (if indicated) is already optimized. Long-term oxygen therapy (LTOT) is added if the daytime Pao 2 is 7.3 kpa or 8 kpa with cor pulmonale or polycythemia. If hypercapnia ( 7.5kPa) develops when the patient is receiving LTOT alone, maintenance nocturnal NIV is started. Laryngeal Function and Tracheostomy Management Effective laryngeal function is a priority. Speaking is encouraged as soon as self-ventilation via a one-way tracheostomy speaking valve is possible without risk of aspiration. Swallowing safety is first assessed with the tracheostomy tube cuff inflated, using oropharyngeal administration of blue food dye followed by tracheal suctioning. If there is no aspiration, dyed fluids and food are tried. Once successful, these steps are repeated with the cuff deflated. Mild aspiration usually improves with swallowing and speaking practice. Regular suctioning can be required, and anticholinergic agents are used if oropharyngeal secretions are profuse. The cuff remains inflated until there is little or no aspiration. The tracheostomy tube is only removed when it is no longer needed for airway protection, secretions access, or ventilation. Patient Selection Patients with a discharge diagnosis of COPD were sought from a database of all patients entered into the PCP. The diagnosis was reviewed on the basis of patient history, referring hospital notes, clinical assessment, spirometry, and radiography. Coexisting pulmonary, neuromuscular, or chest wall disorders, or obstructive sleep apnea were exclusion criteria. Data Collection A retrospective case note review was performed, and the following data were extracted: age at PCP admission; sex; length of stay (LOS) at referring ICU; LOS in the RSSC; FEV 1 ; FVC; ABG levels at intubation, at transfer to, and discharge from the PCP; APACHE (acute physiology and chronic health evaluation) II score at ICU admission; ventilation mode and inspired oxygen concentration at RSSC discharge; and discharge destination. The most recent ventilator settings were sought for patients maintained on NIV after weaning. The Intensive Care National Audit and Research Centre provided APACHE II scores kept on their database when unavailable from our records. Waiver-of-confidentiality agreements were made with the respective referring units prior to data release. Outcomes Weaning success was defined as complete withdrawal of IMV, with or without continuing requirement for nocturnal NIV. Hospital and long-term survival were also measured. Patients with a tracheostomy retained solely for suction were regarded as weaned. Failure to wean was defined as death during the weaning process, or discharge from the RSSC with a continuing requirement for IMV. Long-term survival was assessed using case notes, the hospital computerized patient administration system, and the National Health Service strategic tracing service, which provides information on a patient s vital status accurate to within 2 weeks Original Research
3 Associations were sought between each of the three outcomes and the following variables: age, sex, FEV 1, FVC; APACHE II score at ICU admission; ABG levels at intubation and RSSC arrival; and LOS in the ICU. Associations were also sought for long-term survival with RSSC LOS, ABG levels at RSSC discharge, and the provision of maintenance NIV or LTOT after discharge. Statistical Analysis Data were analyzed using statistical software (SPSS version 12.0 for Windows; SPSS; Chicago, IL). Long-term survival was assessed with Kaplan-Meier charts and life tables. Associations with survival were sought using Cox regression, with grouped data used when statistically significant but nonlinear relationships were found for continuous variables. Normally distributed data were compared using independent t tests, and nonparametric data were compared with the Mann-Whitney U test. Results We accepted 436 patients into the PCP between June 1992 and December 2003, 97 of whom had a discharge diagnosis of COPD. Thirty patients were excluded from the analysis due to coexisting pulmonary, chest-wall or neuromuscular disorders, or obstructive sleep apnea. Demographics, ICU, and weaning data of the remaining 67 patients (36 male) are presented in Table 1. All 67 patients were receiving tracheostomy ventilation on arrival to the RSSC. Three patients died in the RSSC while receiving IMV, leaving 64 patients (95.5%) who were weaned successfully, 2 of whom retained a minitracheostomy for secretion management. All those who were weaned successfully also survived to discharge from the RSSC. Fifty-two Table 1 Patient Demographic, ICU, and Weaning Data Variables Age at PCP admission, yr FEV 1,L FVC, L FEV 1 /FVC, % ph at ICU admission APACHE II score* Intubation Pao 2, kpa Paco 2, kpa Transfer to PCP Pao 2, kpa Paco 2, kpa Discharge from PCP Pao 2, kpa Paco 2, kpa LOS in ICU, d LOS in RSSC, d Median (IQR Range) 66 (55 73) n ( ) n ( ) n (24 50) n ( ) n (7.9) n ( ) n (9 12.7) n ( ) n ( ) n ( ) n ( ) n (14 38) n (16 45) n 67 *Mean (SD). Spirometry data taken from up to 1 year after weaning. patients went directly home, and one patient went to a residential home. Eleven patients were transferred back to their referring hospital, 2 of whom died before discharge. Overall survival to discharge from hospital was 62 of 67 patients (92.5%). APACHE II scores were available for 42 patients (63%); the mean score was 25.5 (SD, 7.9), giving a predicted survival to hospital discharge of 45% compared to an actual survival of 93% for this subgroup. NIV was used in weaning 40 of 67 patients, including 2 of the 3 patients who failed to wean. Twenty-five patients continued with long-term NIV (Table 2). The mean inspiratory pressure (n 21) was 28 cm H 2 O (SD, 4.7 cm H 2 O). Five long-term NIV patients were also discharged with LTOT, and 11 patients were discharged on LTOT alone. Ninety-day survival for the whole group from the date of admission to the weaning program was 88.1%, and median survival was 2.5 years (interquartile range [IQR], 0.7 to 4.6 years). Annual survival rates at 1 to 5 years were 68%, 54%, 40%, 31%, and 25%, respectively (Fig 1). For those weaned from IMV, 1- to 5-year survival rates from PCP admission were 71%, 56%, 41%, 33%, and 26%, respectively; median survival was 2.6 years (IQR, 0.9 to 5.4 years). Patient Characteristics and Correlation With Longterm Survival Neither weaning success nor hospital survival were associated with age; sex; FEV 1 ; FVC; APACHE II score on ICU admission; ABG levels at ICU or PCP admission; LOS in the ICU; or use of NIV during weaning. Long-term survival was inversely associated on univariate analysis with age and LOS in the ICU and the RSSC. Patients aged 70 years on entry to the PCP had a 2.7-fold hazard of dying subsequently, compared to those 70 years old (95% confidence interval [CI], 1.5 to 4.9; p 0.001). Patients who had spent 28 days on ICU were more likely to die in the follow-up period than those in the ICU for 14 days (hazard rate, 2.4; 95% CI, 1.1 to 5.1; p 0.02). Likewise, staying on the RSSC for 28 days was Table 2 Maintenance NIV Patients Compared to Non- NIV Users* Variables NIV No NIV p Value Age at PCP admission, yr 64.5 (53 69) 67.3 ( ) 0.16 LOS in ICU, d 31 ( ) 23 (14 37) 0.85 LOS in RSSC, d 27 ( ) 21 (16 40) 0.61 Discharge Paco 2, kpa 6.6 (0.7) 5.8 (0.9) Discharge Pao 2, kpa 8.3 (1.0) 9.0 (1.1) FEV 1,L 0.5 ( ) 0.7 ( ) 0.08 FVC, L 1.8 ( ) 2.2 ( ) 0.13 *Data are presented as median (IQR) or mean (SD). CHEST / 129 / 1/ JANUARY,
4 term survival was not associated with sex; FEV 1 ; FVC; APACHE II score at ICU admission; ABG levels at ICU or PCP admission, or RSSC discharge; use of NIV during weaning; or provision of LTOT. Discussion Figure 1. Kaplan-Meier plot of cumulative survival for all patients (n 67) from admission to the PCP. associated with poorer long-term survival than a stay of 14 days (hazard rate, 4.0; 95% CI, 1.5 to 10.7; p 0.005). Long-term NIV was associated with a survival advantage on univariate analysis (hazard rate, 0.50; 95% CI, 0.26 to 0.96; p 0.04) and after correcting for age and LOS (hazard rate, 0.48; 95% CI, 0.24 to 0.95; p 0.03). Median survival for patients receiving maintenance NIV was 3.3 years (IQR, 1.3 to 7.9 years) and 1.6 years (IQR, 0.48 to 4.2 years) for those discharged without it (Fig 2). Long- Figure 2. Kaplan-Meier plot of cumulative survival according to discharge NIV status (n 64). Exacerbations of COPD requiring hospitalization are associated with substantial hospital and longerterm mortality. 3,4,6 9,14 Those cases complicated by acute ventilatory failure frequently require IMV, and weaning can be difficult. 1,2,10,15 We report a 95.5% success rate for weaning COPD patients from IMV and 92.5% survival to hospital discharge. These subjects had recovered from the acute illness that precipitated their intubation, were hemodynamically stable, and received ventilation via tracheostomy. The median survival for those patients weaned from IMV is 2.6 years. Survival rates at 1, 2, and 5 years are 71%, 56%, and 26%, respectively. These outcomes represent the application of a process of care, including the use of NIV, by a specialist multidisciplinary team. The interpretation of our data is limited by their retrospective and uncontrolled nature. This is also the case for most other published reports of COPD patients receiving invasive ventilation (Table 3). Our results appear to compare favorably with these, which may be explained by the patients in our series having less severe disease. However, the data for lung function, ph at acute presentation, and Paco 2 at various stages of admission (Table 1) confirm that our patients had significant airflow obstruction with severe ventilatory failure. Only Menzies et al 7 provide equivalent data to allow comparison and, on the basis of FEV 1 and ABG levels at acute presentation, our patients had a similar degree of airflow obstruction and respiratory failure. Our results do not only compare well with data describing COPD patients needing IMV. In the 2003 National COPD Audit (First Report of the 2003 National COPD Audit [mail-merge document sent out by the Royal College of Physicians to UK hospitals, 2004]) the median Paco 2 on admission was 5.9 kpa (IQR, 5.0 to 7.3 kpa). In 1,815 episodes (23%) arterial ph was 7.35 at some point, but ventilatory support (IMV or NIV) was instituted in just 39% of these cases. There may be several explanations for this, but it demonstrates that in the United Kingdom the threshold for intubating patients with COPD is high. By contrast, all the patients in our series were intubated for ventilatory failure. When considered alongside the APACHE II score, lung function, and ABG data at intubation (Table 1), it suggests our series has a more severely 136 Original Research
5 Table 3 Published Survival Rates at 1 Year for COPD Patients Who Required IMV Source Year Patients Receiving IMV, No. % Weaned % Survival to Discharge 1-yr Survival, % RSSC Schönhofer et al 6 * Nava et al 9 * Stauffer et al Menzies et al Spicher and White Witek et al *Weaning center. One-year survival from start of weaning. One-year survival from time of discharge. One-year survival from intubation. One-year survival from successful weaning. ill group of patients than that described in the National COPD Audit. Nonetheless, the hospital and 90-day mortality rates (7.5% and 11.9%, respectively) are similar to those from the audit (7.5% and 15.5%). The results for our series may be due to selection bias. Those patients who were referred for weaning had survived an acute severe illness and prolonged IMV at their referring ICU. We could therefore be describing a population of survivors, although our data suggest that a greater LOS in the ICU was associated with a worse longer-term outcome. Further exploration of this would require mortality data from the referring ICUs for all patients with COPD. Comparing each patient transferred to the RSSC with a COPD patient identified from their referring ICU, matching for factors including age, APACHE II score, and ICU LOS, could clarify whether admission to the PCP confers a weaning and survival advantage. Without this information, selection bias cannot be excluded, but the condition of these patients was poor enough to prevent them responding to standard management including conventional critical care unit weaning techniques. It is also possible that the weaning results and survival data represent the positive impact of our process of care. IMV has a number of complications, 16 particularly when prolonged, with an increasing risk of ventilator-associated pneumonia and consequent mortality. 17,18 Both Nava et al 9 and Schönhofer et al 6 reported better survival for those patients successfully weaned from IMV. Another series 19 describing COPD patients receiving prolonged IMV reported a median survival of only 5 months. It seems likely that weaning the majority of our patients had a positive impact on both hospital and long-term survival. There are few studies to guide the choice of ventilation mode during weaning. Esteban et al 20 demonstrated faster weaning using spontaneous breathing than for either PSV or intermittent mandatory ventilation. However, criteria for determining intolerance of weaning differed between the spontaneous breathing and PSV groups, which may have selectively delayed weaning in the latter. Brochard et al 21 found an advantage for PSV over both synchronized intermittent mandatory ventilation and T- piece trial in terms of weaning failures. These studies employed stepwise reduction of pressure support. Neither study examined the combination of an optimal level of PSV with USB. Optimal PSV supports the spontaneous inspiratory effort, allowing diaphragmatic activity and possibly training, while preventing its fatigue. 22,23 Combining this with USB may have contributed to the high rate of weaning success in our series. NIV is a relatively new weaning technique. Of the series in Table 3, only Schönhofer et al 6 and ourselves used NIV during weaning. We introduce NIV when patients fail to progress with self-ventilation due to the development of respiratory distress or hypercapnia. Similarly, Schönhofer et al 6 administered NIV to 55 COPD patients who acquired hypercapnia when off IMV. There was no report of NIV influence on weaning outcome, but the 39 patients who tolerated it continued with long-term NIV. There are other data supporting the use of NIV in weaning. In a trial 24 of 50 COPD patients still requiring IMV after 48 h, 25 patients were randomized to extubation and NIV and 25 patients to weaning without NIV. In the NIV study arm, there were reductions in duration of IMV, ICU LOS, and incidence of ventilator-associated pneumonia; and increases in 60-day survival, probability of survival during weaning, and weaning success. Hilbert et al 25 compared 30 COPD patients receiving NIV for ventilatory failure after extubation with 30 historical control subjects. The NIV group had lower reintubation rates, duration of ventilatory support, and ICU LOS. A larger randomized trial 26 compared CHEST / 129 / 1/ JANUARY,
6 NIV to standard medical therapy for respiratory failure after extubation. The trial was stopped early due to a higher rate of death in the NIV study arm, apparently due to mortality differences in those who were reintubated. Reintubation rates were similar, but time to reintubation was longer in those receiving NIV (p 0.02), suggesting that it led to delay in reinstitution of IMV. Not all patients had hypercapnia, and only 23 of the 221 patients were intubated for COPD. Of those, the rate of reintubation was lower in the NIV study arm (not significant), but the sample was too small to allow further analysis. The applicability of these results to COPD patients intubated for ventilatory failure is therefore limited. Although our retrospective series is uncontrolled and comprises patients who had a more protracted ICU admission, the results suggest a role for the selective use of NIV when weaning COPD patients from IMV. Maintenance NIV after discharge was associated with better long-term survival in our series. Schönhofer et al 6 found that survival duration was associated with the use of NIV (p ), but there was no subgroup analysis for COPD. Case series have reported relatively good survival for COPD patients treated with NIV for chronic ventilatory failure. 27,28 Randomized controlled trials 29,30 have not shown a survival benefit, but it is not clear they achieved effective nocturnal ventilation. The mean inspiratory pressures were set at only 12 to 14 cm H 2 O, and the efficacy of nocturnal ventilation was assessed either clinically 29 or with oximetry. 30 Nocturnal carbon dioxide tensions were not assessed, and low oxygen saturations were corrected by increasing inspired oxygen rather than the level of ventilatory support. Higher inspiratory pressures are required to normalize Paco We used nocturnal oximetry and Ptco 2 plus daytime ABG levels to guide pressure titration, aiming to normalize Paco 2. The mean inspiratory pressure required was 28 cm H 2 O. The allocation of long-term NIV in our group was based on clinical criteria and not randomized. The non-niv group, although similar to those receiving NIV in terms of age, LOS, and lung function, had statistically significantly better ABG levels at discharge (Table 2). The survival advantage, despite worse ABG levels, for those receiving maintenance NIV suggests that even if it does not fully correct ventilatory failure, NIV may still improve survival. The study by Chu et al 14 examined outcomes of COPD patients who received hospital NIV for acute ventilatory failure. They found that 63% had a further episode of acute hypercapnia requiring assisted ventilation (NIV or IMV) within 1 year of discharge, and 49% had died. All the patients in our series had a history of acute severe ventilatory failure. It may be that domiciliary NIV protects these patients during subsequent exacerbations of COPD, reducing the degree of acute ventilatory deterioration and its associated mortality. We report a 95.5% weaning rate and 92.5% survival to discharge for COPD patients dependent on IMV who were admitted to our center. These outcomes are better than predicted from the APACHE II scores or in previously reported series. Bias in the referral of patients to our service cannot be excluded, but all patients had severe COPD and had failed to progress with weaning in their local ICU. Our results were achieved through the application of a process of care by a multidisciplinary team, which includes the combination of PSV with unsupported spontaneous breathing and the use of NIV. The survival advantage demonstrated for patients discharged on maintenance NIV suggests it has a role in the management of a subgroup of patients with severe COPD and a history of difficulty in weaning from IMV. ACKNOWLEDGMENT: The authors thank the Intensive Care National Audit and Research Centre for their help in providing APACHE II data, and Fay Cafferty for statistical input. References 1 Brochard L, Mancebo J, Wysocki M, et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1995; 333: Plant PK, Owen JL, Elliott MW. Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial. Lancet 2000; 355: Stauffer JL, Fayter NA, Graves B, et al. Survival following mechanical ventilation for acute respiratory failure in adult men. Chest 1993; 104: Spicher JE, White DP. Outcome and function following prolonged mechanical ventilation. Arch Intern Med 1987; 147: Swinburne AJ, Fedullo AJ, Bixby K, et al. Respiratory failure in the elderly: analysis of outcome after treatment with mechanical ventilation. Arch Intern Med 1993; 153: Schönhofer B, Euteneuer S, Nava S, et al. Survival of mechanically ventilated patients admitted to a specialised weaning centre. Intensive Care Med 2002; 28: Menzies R, Gibbons W, Goldberg P. Determinants of weaning and survival among patients with COPD who require mechanical ventilation for acute respiratory failure. Chest 1989; 95: Witek TJ, Schachter EN, Dean NL, et al. Mechanically assisted ventilation in a community hospital. Arch Intern Med 1985; 145: Nava S, Rubini F, Zanotti E, et al. Survival and prediction of successful ventilator weaning in COPD patients requiring mechanical ventilation for more than 21 days. Eur Respir J 1994; 7: Esteban A, Alia I, Ibanez J, et al. Modes of mechanical ventilation and weaning: a national survey of Spanish hospitals. Chest 1994; 106: Original Research
7 11 Gracey DR, Viggiano RW, Naessens JM, et al. Outcomes of patients admitted to a chronic ventilator-dependent unit in an acute-care hospital. Mayo Clin Proc 1992; 67: Smith IE, Shneerson JM. A progressive care programme for prolonged ventilatory failure: analysis of outcome. Br J Anaesth 1995; 75: NHS Strategic Tracing Service. Available at: nhsia.nhs.ukhttp:// Accessed December 5, Chu CM, Chan VL, Lin AW, et al. Readmission rates and life-threatening events in COPD survivors treated with noninvasive ventilation for acute hypercapnic respiratory failure. Thorax 2004; 59: Connors AF, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. Am J Respir Crit Care Med 1996; 154: Tobin MJ. Mechanical ventilation. N Engl J Med 1994; 330: Fagon JY, Chastre J, Domart Y, et al. Nosocomial pneumonia in patients receiving continuous mechanical ventilation: prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques. Am Rev Respir Dis 1989; 139: Kollef MH, Silver P, Murphy DM, et al. The effect of late-onset ventilator-associated pneumonia in determining patient mortality. Chest 1995; 108: Votto J, Brancifort JM, Scalise PJ, et al. COPD and other diseases in chronically ventilated patients in a prolonged respiratory care unit: a retrospective 20-year survival study. Chest 1998; 113: Esteban A, Frutos F, Tobin M, et al. A comparison of four methods of weaning patients from mechanical ventilation. N Engl J Med 1995; 332: Brochard L, Rauss A, Benito S, et al. Comparison of three methods of gradual withdrawal from ventilatory support during weaning from mechanical ventilation. Am J Respir Crit Care Med 1994; 150: Brochard L, Harf A, Lorino H, et al. Inspiratory pressure support prevents diaphragmatic fatigue during weaning from mechanical ventilation. Am Rev Respir Dis 1989; 139: Shneerson J. Muscle dysfunction and non-invasive ventilation. Monaldi Arch Chest Dis 2003; 59: Nava S, Ambrosino N, Clini E, et al. Noninvasive mechanical ventilation in the weaning of patients with respiratory failure due to chronic obstructive pulmonary disease: a randomized, controlled trial. Ann Intern Med 1998; 128: Hilbert G, Gruson D, Portel L, et al. Noninvasive pressure support ventilation in COPD patients with postextubation hypercapnic respiratory insufficiency. Eur Respir J 1998; 11: Esteban A, Frutos-Vivar F, Ferguson ND, et al. Noninvasive positive-pressure ventilation for respiratory failure after extubation. N Engl J Med 2004; 350: Jones SE, Packham S, Hebden M, et al. Domiciliary nocturnal intermittent positive pressure ventilation in patients with respiratory failure due to severe COPD: long term follow up and effect on survival. Thorax 1998; 53: Sivasothy P, Smith IE, Shneerson J. Mask intermittent positive pressure ventilation in chronic hypercapnic respiratory failure due to chronic obstructive pulmonary disease. Eur Respir J 1998; 11: Casanova C, Celli BR, Tost L, et al. Long-term controlled trial of nocturnal nasal positive pressure ventilation in patients with severe COPD. Chest 2000; 118: Clini E, Sturani C, Rossi A, et al. The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients. Eur Respir J 2002; 20: Windisch W, Vogel M, Sorichter S, et al. Normocapnia during nippv in chronic hypercapnic COPD reduces subsequent spontaneous Paco 2. Respir Med 2002; 96: CHEST / 129 / 1/ JANUARY,
Weaning from prolonged invasive ventilation in motor neurone disease: analysis of outcomes and survival
Weaning from prolonged invasive ventilation in motor neurone disease: analysis of outcomes and survival Corresponding author: Ms R Chadwick Respiratory Support and Sleep Centre Papworth Hospital NHS Foundation
More informationNon-invasive ventilation in acute exacerbations of chronic obstructive pulmonary disease: long term survival and predictors of in-hospital outcome
708 Department of Respiratory Medicine, St James s University Hospital, Leeds LS9 7TF, UK P K Plant JLOwen M W Elliott Correspondence to: Dr P K Plant Paul.Plant@ gw.sjsuh.northy.nhs.uk Received 25 July
More information, OR 8.73 (95% CI
550 Thorax 2000;55:550 554 Department of Respiratory Medicine, St James s University Hospital, Leeds LS9 7TF, UK P K Plant JLOwen M W Elliott Correspondence to: Dr P K Plant email: mbriggs@alwoodley.u-net.com
More informationM ost patients who require mechanical ventilation
187 MECHANICAL VENTILATION Outcomes, cost and long term survival of patients referred to a regional weaning centre D V Pilcher, M J Bailey, D F Treacher, S Hamid, A J Williams, A C Davidson... See end
More informationHospital outcomes and long-term survival after referral to a specialized weaning unit
British Journal of Anaesthesia, 118 (4): 563 9 (2017) doi: 10.1093/bja/aex031 Critical Care CRITICAL CARE Hospital outcomes and long-term survival after referral to a specialized weaning unit M. G. Davies*,
More informationAuthors: Corresponding author: Yasuhiro Kamii Tel: Fax:
Investigation of chronic obstructive pulmonary disease patients discharged without home mechanical ventilation after in-hospital use of acute non-invasive ventilation Authors: Yasuhiro Kamii, MD Hirotoshi
More informationPaCO2 Six months after the Initiation of Long-term Noninvasive Ventilation in Patients with COPD
ORIGINAL ARTICLE PaCO2 Six months after the Initiation of Long-term Noninvasive Ventilation in Patients with COPD Tomomasa Tsuboi 1,3, Toru Oga 1, Kazuko Machida 2,KensukeSumi 3, Susumu Oguri 3, Atsuo
More informationWeb Appendix 1: Literature search strategy. BTS Acute Hypercapnic Respiratory Failure (AHRF) write-up. Sources to be searched for the guidelines;
Web Appendix 1: Literature search strategy BTS Acute Hypercapnic Respiratory Failure (AHRF) write-up Sources to be searched for the guidelines; Cochrane Database of Systematic Reviews (CDSR) Database of
More informationNoninvasive pressure support ventilation in COPD patients with postextubation hypercapnic respiratory insufficiency
Eur Respir J 1998; 11: 1349 1353 DOI: 10.1183/09031936.98.11061349 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1998 European Respiratory Journal ISSN 0903-1936 Noninvasive pressure support
More informationWhat is the next best step?
Noninvasive Ventilation William Janssen, M.D. Assistant Professor of Medicine National Jewish Health University of Colorado Denver Health Sciences Center What is the next best step? 65 year old female
More informationAcute exacerbations are common in patients with
Predicting the Result of Noninvasive Ventilation in Severe Acute Exacerbations of Patients With Chronic Airflow Limitation* Antonio Antón, MD; Rosa Güell, MD; Juan Gómez, MD; José Serrano, MD; Abilio Castellano,
More informationWeaning from mechanical ventilation
Weaning from mechanical ventilation Jeremy Lermitte BM FRCA Mark J Garfield MB ChB FRCA Mechanical ventilation has gone through a dramatic evolution over a relatively short space of time. After the Copenhagen
More informationEffectiveness and safety of a protocolized mechanical ventilation and weaning strategy of COPD patients by respiratory therapists
Original Article Effectiveness and safety of a protocolized mechanical ventilation and weaning strategy of COPD patients by respiratory therapists Cenk Kirakli, Ozlem Ediboglu, Ilknur Naz, Pinar Cimen,
More informationChronic Obstructive Pulmonary Disease (COPD) Measures Document
Chronic Obstructive Pulmonary Disease (COPD) Measures Document COPD Version: 3 - covering patients discharged between 01/10/2017 and present. Programme Lead: Jo Higgins Clinical Lead: Dr Paul Albert Number
More informationAcute noninvasive ventilation what s the evidence? Respiratory Medicine Update: Royal College of Physicians & BTS Thu 28 th January 2016
Acute noninvasive ventilation what s the evidence? Respiratory Medicine Update: Royal College of Physicians & BTS Thu 28 th January 2016 Annabel Nickol Consultant in Respiratory Medicine, Sleep & Ventilation
More informationLiberation from Mechanical Ventilation in Critically Ill Adults
Liberation from Mechanical Ventilation in Critically Ill Adults 2017 ACCP/ATS Clinical Practice Guidelines Timothy D. Girard, MD, MSCI Clinical Research, Investigation, and Systems Modeling of Acute Illness
More informationN on-invasive ventilation (NIV) has been shown in
1020 CHRONIC OBSTRUCTIVE PULMONARY DISEASE Readmission rates and life threatening events in COPD survivors treated with non-invasive ventilation for acute hypercapnic respiratory failure C M Chu, V L Chan,
More informationNIV - BI-LEVEL POSITIVE AIRWAY PRESSURE (BIPAP)
Introduction NIV - BI-LEVEL POSITIVE AIRWAY PRESSURE (BIPAP) Noninvasive ventilation (NIV) is a method of delivering oxygen by positive pressure mask that allows for the prevention or postponement of invasive
More informationThe Egyptian Society of Chest Diseases and Tuberculosis. Egyptian Journal of Chest Diseases and Tuberculosis
Egyptian Journal of Chest Diseases and Tuberculosis (2012) 61, 95 101 The Egyptian Society of Chest Diseases and Tuberculosis Egyptian Journal of Chest Diseases and Tuberculosis www.elsevier.com/locate/ejcdt
More informationRon Hosp, MS-HSA, RRT Regional Respiratory Specialist. This program has been approved for 1 hour of continuing education credit.
Ron Hosp, MS-HSA, RRT Regional Respiratory Specialist This program has been approved for 1 hour of continuing education credit. Course Objectives Identify at least four goals of home NIV Identify candidates
More informationBTS/ICS Guidelines for the ventilatory management of acute hypercapnic respiratory failure in adults
BTS/ICS Guidelines for the ventilatory management of acute hypercapnic respiratory failure in adults British Thoracic Society Intensive Care Society Introduction Acute Hypercapnic Respiratory Failure (AHRF)
More informationAcute NIV in COPD and what happens next. Dr Rachael Evans PhD Associate Professor, Respiratory Medicine, Glenfield Hospital
Acute NIV in COPD and what happens next Dr Rachael Evans PhD Associate Professor, Respiratory Medicine, Glenfield Hospital Content Scenarios Evidence based medicine for the first 24 hrs Who should we refer
More informationOver the last several years various national and
Recommendations for the Management of COPD* Gary T. Ferguson, MD, FCCP Three sets of guidelines for the management of COPD that are widely recognized (from the European Respiratory Society [ERS], American
More informationInvasive mechanical ventilation is
A randomized, controlled trial of the role of weaning predictors in clinical decision making* Maged A. Tanios, MD, MPH; Michael L. Nevins, MD; Katherine P. Hendra, MD; Pierre Cardinal, MD; Jill E. Allan,
More informationBilevel positive airway pressure nasal mask ventilation in patients with acute hypercapnic respiratory failure
Bilevel positive airway pressure nasal mask ventilation in patients with acute hypercapnic respiratory failure CK Chan, KS Lau, HC Fan, CW Lam The efficacy and complications of bilevel positive airway
More informationTest Bank Pilbeam's Mechanical Ventilation Physiological and Clinical Applications 6th Edition Cairo
Instant dowload and all chapters Test Bank Pilbeam's Mechanical Ventilation Physiological and Clinical Applications 6th Edition Cairo https://testbanklab.com/download/test-bank-pilbeams-mechanical-ventilation-physiologicalclinical-applications-6th-edition-cairo/
More informationNIV in Acute Respiratory Failure: Where we fail? Dr Shrikanth Srinivasan MD,DNB,FNB,EDIC Consultant, Critical Care Medicine Medanta, The Medicity
NIV in Acute Respiratory Failure: Where we fail? Dr Shrikanth Srinivasan MD,DNB,FNB,EDIC Consultant, Critical Care Medicine Medanta, The Medicity Use of NIV 1998-2010 50 45 40 35 30 25 20 15 10 5 0 1998
More informationPAPER DE LA VNI EN LA RETIRADA DE LA VENTILACIÓ INVASIVA I FRACÀS D EXTUBACIÓ
PAPER DE LA VNI EN LA RETIRADA DE LA VENTILACIÓ INVASIVA I FRACÀS D EXTUBACIÓ Dr. Miquel Ferrer UVIIR, Servei de Pneumologia, Hospital Clínic, IDIBAPS, CibeRes, Barcelona. E- mail: miferrer@clinic.ub.es
More informationMechanical Ventilation of the Patient with Neuromuscular Disease
Mechanical Ventilation of the Patient with Neuromuscular Disease Dean Hess PhD RRT Associate Professor of Anesthesia, Harvard Medical School Assistant Director of Respiratory Care, Massachusetts General
More informationAverage volume-assured pressure support
Focused review Average volume-assured pressure support Abdurahim Aloud MD Abstract Average volume-assured pressure support (AVAPS) is a relatively new mode of noninvasive positive pressure ventilation
More informationAdaptive support ventilation for faster weaning in COPD: a randomised controlled trial
Eur Respir J 2011; 38: 774 780 DOI: 10.1183/09031936.00081510 CopyrightßERS 2011 Adaptive support ventilation for faster weaning in COPD: a randomised controlled trial C. Kirakli*, I. Ozdemir #, Z.Z. Ucar*,
More informationPrepared by : Bayan Kaddourah RN,MHM. GICU Clinical Instructor
Mechanical Ventilation Prepared by : Bayan Kaddourah RN,MHM. GICU Clinical Instructor 1 Definition Is a supportive therapy to facilitate gas exchange. Most ventilatory support requires an artificial airway.
More informationPapers. Abstract. Methods. Introduction. Josephine V Lightowler, Jadwiga A Wedzicha, Mark W Elliott, Felix S F Ram
Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis Josephine V Lightowler,
More informationBi-Level Therapy: Boosting Comfort & Compliance in Apnea Patients
Bi-Level Therapy: Boosting Comfort & Compliance in Apnea Patients Objectives Describe nocturnal ventilation characteristics that may indicate underlying conditions and benefits of bilevel therapy for specific
More informationISPUB.COM. S Venkatram, S Rachmale, B Kanna, A Soni INTRODUCTION METHODS AND MATERIALS DESIGN SETTING INCLUSION CRITERIA
ISPUB.COM The Internet Journal of Pulmonary Medicine Volume 12 Number 1 Non-Invasive Positive Pressure Ventilation Compared To Invasive Mechanical Ventilation Among Patients With COPD Exacerbations In
More informationEFFICACY OF BIPAP IN PATIENTS ADMITTED WITH HYPERCAPNIC RESPIRATORY FAILURE; AN EXPERIENCE AT A TERTIARY CARE HOSPITAL
ORIGINAL ARTICLE EFFICACY OF BIPAP IN PATIENTS ADMITTED WITH HYPERCAPNIC RESPIRATORY FAILURE; AN EXPERIENCE AT A TERTIARY CARE HOSPITAL Hussain Ahmad*, Saadia Ashraf*, Rukhsana Javed Farooqi*, Mukhtiar
More informationHypoventilation? Obstructive Sleep Apnea? Different Tests, Different Treatment
Hypoventilation? Obstructive Sleep Apnea? Different Tests, Different Treatment Judith R. Fischer, MSLS, Editor, Ventilator-Assisted Living (fischer.judith@sbcglobal.net) Thanks to Josh Benditt, MD, University
More informationKeywords: Non-invasive mechanical ventilation, Respiratory Failure, Respiratory muscles, Hypercapnia, Breathing pattern.
Monaldi Arch Chest Dis 2004; 61: 2, 81-85 ORIGINAL ARTICLE Inspiratory muscle workload due to dynamic intrinsic PEEP in stable COPD patients: effects of two different settings of non-invasive pressure-support
More informationThey are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:
bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest
More informationNon-Invasive Ventilation
Khusrav Bajan Head Emergency Medicine, Consultant Intensivist & Physician, P.D. Hinduja National Hospital & M.R.C. 112 And the Lord God formed man of the dust of the ground and breathed into his nostrils
More informationPediatric Patients. Neuromuscular Disease. Teera Kijmassuwan, MD Phetcharat Netmuy, B.N.S., MA Oranee Sanmaneechai, MD : Preceptor
Patient Management Pediatric Patients with Neuromuscular Disease Teera Kijmassuwan, MD Phetcharat Netmuy, B.N.S., MA Oranee Sanmaneechai, MD : Preceptor Case Thai boy 1 year old Present with Respiratory
More informationComparison of Two Methods for Weaning Patients with Chronic Obstructive Pulmonary Disease Requiring Mechanical Ventilation for More Than 15 Days
Comparison of Two Methods for Weaning Patients with Chronic Obstructive Pulmonary Disease Requiring Mechanical Ventilation for More Than 15 Days MICHELE VITACCA, ANDREA VIANELLO, DANIELE COLOMBO, ENRICO
More informationHome Mechanical Ventilation
The International Convention Centre (ICC), Birmingham 11 12 September 2017 Home Mechanical Ventilation Martin Latham Nurse Specialist in Sleep Disordered Breathing St James s University Hospital Leeds
More informationRecent Advances in Respiratory Medicine
Recent Advances in Respiratory Medicine Dr. R KUMAR Pulmonologist Non Invasive Ventilation (NIV) NIV Noninvasive ventilation (NIV) refers to the administration of ventilatory support without using an invasive
More informationNIV in acute hypoxic respiratory failure
All course materials, including the original lecture, are available as webcasts/podcasts at www.ers-education. org/niv2009.htm NIV in acute hypoxic respiratory failure Educational aims This presentation
More informationBTS Guideline for Home Oxygen use in adults Appendix 9 (online only) Key Questions - PICO 10 December 2012
BTS Guideline for Home Oxygen use in adults Appendix 9 (online only) Key Questions - PICO 10 December 2012 Evidence base for Home Oxygen therapy in COPD, non-copd respiratory disease and nonrespiratory
More informationSupplementary Online Content
Supplementary Online Content Murphy PB, Rehal S, Arbane G, et al. Effect of home noninvasive ventilation with oxygen therapy vs oxygen therapy alone on hospital readmission or death after an acute COPD
More informationNoninvasive mechanical ventilation in acute respiratory failure
Eur Respir J, 1996, 9, 795 807 DOI: 10.1183/09031936.96.09040795 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1996 European Respiratory Journal ISSN 0903-1936 SERIES: 'CLINICAL PHYSIOLOGY
More informationThey are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:
bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest
More informationConcerns and Controversial Issues in NPPV. Concerns and Controversial Issues in Noninvasive Positive Pressure Ventilation
: Common Therapy in Daily Practice Concerns and Controversial Issues in Noninvasive Positive Pressure Ventilation Rongchang Chen Guangzhou Institute of Respiratory Disease as the first choice of mechanical
More informationThe Rapid Shallow Breathing Index as a Predictor of Failure of Noninvasive Ventilation for Patients With Acute Respiratory Failure
Original Research The Rapid Shallow Breathing Index as a Predictor of Failure of Noninvasive Ventilation for Patients With Acute Respiratory Failure Katherine M Berg MD, Gerald R Lang RRT, Justin D Salciccioli,
More informationNoninvasive Ventilation: Non-COPD Applications
Noninvasive Ventilation: Non-COPD Applications NONINVASIVE MECHANICAL VENTILATION Why Noninvasive Ventilation? Avoids upper A respiratory airway trauma system lacerations, protective hemorrhage strategy
More informationEvaluation of Clinical Data and Mortality among COPD Patients Receiving Domiciliary NIMV Therapy
Turk Thorac J 2014; 15: 112-6 DOI: 10.5152/ttd.2014.3852 ORIGINAL INVESTIGATION Evaluation of Clinical Data and Mortality among COPD Patients Receiving Domiciliary NIMV Therapy Tacettin Örnek, Fatma Erboy,
More informationExtubation Failure & Delay in Brain-Injured Patients
Extubation Failure & Delay in Brain-Injured Patients Niall D. Ferguson, MD, FRCPC, MSc Director, Critical Care Medicine University Health Network & Mount Sinai Hospital Associate Professor of Medicine
More informationSample Case Study. The patient was a 77-year-old female who arrived to the emergency room on
Sample Case Study The patient was a 77-year-old female who arrived to the emergency room on February 25 th with a chief complaint of shortness of breath and a deteriorating pulmonary status along with
More informationNoninvasive ventilation: Selection of patient, interfaces, initiation and weaning
CME article Johnson S, et al: Noninvasive ventilation Noninvasive ventilation: Selection of patient, interfaces, initiation and weaning Saumy Johnson, Ramesh Unnikrishnan * Email: ramesh.unnikrishnan@manipal.edu
More informationUniversity of Groningen. Chronic non-invasive ventilation in COPD Struik, Fransien. DOI: /j.rmed /j.jclinepi
University of Groningen Chronic non-invasive ventilation in COPD Struik, Fransien DOI: 10.1016/j.rmed.2013.10.007 10.1016/j.jclinepi.2013.04.013 IMPORTANT NOTE: You are advised to consult the publisher's
More informationOutcome at three months of COPD patients with acute hypercapnic respiratory failure treated with NPPV in an Acute Medicine Ward
emergency care journal Outcome at three months of COPD patients with acute hypercapnic respiratory failure treated with NPPV in an Acute Medicine Ward Fabrizio Vincenti*, Adriano Basile*, Ernesto Contro*,
More information(Non)-invasive ventilation: transition from PICU to home. Christian Dohna-Schwake
(Non)-invasive ventilation: transition from PICU to home Christian Dohna-Schwake Increased use of NIV in PICUs over last 15 years First choice of respiratory support in many diseases Common temporary indications:
More informationChronic Obstructive Pulmonary Diseases:
313 High Intensity Non-Invasive Ventilation for Hypercapnic COPD Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation Original Research High Intensity Non-Invasive Positive Pressure Ventilation
More informationPolicy Specific Section: October 1, 2010 January 21, 2013
Medical Policy Bi-level Positive Airway Pressure (BPAP/NPPV) Type: Medical Necessity/Not Medical Necessity Policy Specific Section: Durable Medical Equipment Original Policy Date: Effective Date: October
More informationTherapist-implemented protocols have been used. Outcomes in Post-ICU Mechanical Ventilation* A Therapist-Implemented Weaning Protocol
Outcomes in Post-ICU Mechanical Ventilation* A Therapist-Implemented Weaning Protocol David J. Scheinhorn, MD, FCCP; David C. Chao, MD, FCCP; Meg Stearn-Hassenpflug, MS, RD; and Wayne A. Wallace, BA, RRT,
More informationPredictors of Successful Noninvasive Ventilation Treatment for Patients Suffering Acute Respiratory Failure
ORIGINAL ARTICLE Predictors of Successful Noninvasive Ventilation Treatment for Patients Suffering Acute Respiratory Failure Ming-Shian Lin 1, How-Ran Guo 2,3, Ming-Hua Huang 4, Cheng-Ren Chen 1, Chen-Long
More information2/13/2018 OBESITY HYPOVENTILATION SYNDROME
OBESITY HYPOVENTILATION SYNDROME David Claman, MD UCSF Professor of Medicine Director, UCSF Sleep Disorders Center Disclosures: None. 1 COMPLICATIONS OF OSA Cardiovascular HTN, CHF, CVA, arrhythmia, Pulm
More informationRespiratory Medicine. Some pet peeves and other random topics. Kyle Perrin
Respiratory Medicine Some pet peeves and other random topics Kyle Perrin Overview 1. Acute asthma Severity assessment and management 2. Acute COPD NIV and other management 3. Respiratory problems in the
More informationThe Importance of Controlling P aco2 Throughout Long-Term Noninvasive Ventilation
The Importance of Controlling P aco2 Throughout Long-Term Noninvasive Ventilation Tomomasa Tsuboi MD PhD, Toru Oga MD PhD, Kensuke Sumi MD PhD, Kazuko Machida MD, Motoharu Ohi MD PhD, and Kazuo Chin MD
More informationAudit of acute admissions of COPD: standards of care and management in the hospital setting
Eur Respir J 2001; 17: 343 349 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2001 European Respiratory Journal ISSN 0903-1936 Audit of acute admissions of COPD: standards of care and management
More informationPOLICY. Number: Title: APPLICATION OF NON INVASIVE VENTILATION FOR ACUTE RESPIRATORY FAILURE. Authorization
POLICY Number: 7311-60-024 Title: APPLICATION OF NON INVASIVE VENTILATION FOR ACUTE RESPIRATORY FAILURE Authorization [ ] President and CEO [ x ] Vice President, Finance and Corporate Services Source:
More informationBiLevel Pressure Device
PROCEDURE - Page 1 of 7 Purpose Scope Classes/ Goals Define indications and care settings for acute and chronic initiation of Noninvasive Positive Pressure Ventilation. Identify the role of Respiratory
More informationNasal ventilation in COPD exacerbations: early and late results of a prospective, controlled
Eur Respir J 2000; 15: 98±104 Printed in UK ± all rights reserved Copyright #ERS Journals Ltd 2000 European Respiratory Journal ISSN 0903-1936 Nasal ventilation in COPD exacerbations: early and late results
More informationMechanical Ventilation in COPD patients
Mechanical Ventilation in COPD patients Θεόδωρος Βασιλακόπουλος Καθηγητής Πνευμονολογίας-Εντατικής Θεραπείας Εθνικό & Καποδιστριακό Πανεπιστήμιο Αθηνών Νοσοκομείο «ο Ευαγγελισμός» Adjunct Professor, McGill
More informationRespiratory Failure how the respiratory physicians deal with airway emergencies
Respiratory Failure how the respiratory physicians deal with airway emergencies Dr Michael Davies MD FRCP Consultant Respiratory Physician Respiratory Support and Sleep Centre Papworth Hospital NHS Foundation
More informationJournal Club American Journal of Respiratory and Critical Care Medicine. Zhang Junyi
Journal Club 2018 American Journal of Respiratory and Critical Care Medicine Zhang Junyi 2018.11.23 Background Mechanical Ventilation A life-saving technique used worldwide 15 million patients annually
More informationCOPD Challenge CASE PRESENTATION
Chronic obstructive pulmonary disease (COPD) exacerbations may make up more than 10% of acute medical admissions [1], and they are increasingly recognised as a cause of significant morbidity and mortality
More informationExclusion Criteria 1. Operator or supervisor feels specific intra- procedural laryngoscopy device will be required.
FELLOW Study Data Analysis Plan Direct Laryngoscopy vs Video Laryngoscopy Background Respiratory failure requiring endotracheal intubation occurs in as many as 40% of critically ill patients. Procedural
More informationNoninvasive Mechanical Ventilation in Children ศ.พญ.อร ณวรรณ พฤทธ พ นธ หน วยโรคระบบหายใจเด ก ภาคว ชาก มารเวชศาสตร คณะแพทยศาสตร โรงพยาบาลรามาธ บด
Noninvasive Mechanical Ventilation in Children ศ.พญ.อร ณวรรณ พฤทธ พ นธ หน วยโรคระบบหายใจเด ก ภาคว ชาก มารเวชศาสตร คณะแพทยศาสตร โรงพยาบาลรามาธ บด Noninvasive Mechanical Ventilation Provide support without
More informationLong-term non-invasive ventilation in cystic fibrosis Experience over two decades
Journal of Cystic Fibrosis 11 (2012) 187 192 www.elsevier.com/locate/jcf Original Article Long-term non-invasive ventilation in cystic fibrosis Experience over two decades William G. Flight a, b,, Jonathan
More informationMémoire de Maîtrise en médecine No 778. Etudiant Tania Soccorsi. Tuteur Dr Jean-Pierre Revelly Service de Médecine Intensive Adulte, CHUV
Mémoire de Maîtrise en médecine No 778 Clinical characteristics and outcome of patients admitted to a medicosurgical ICU requiring non invasive ventilation (NIV) for hypercapnic respiratory failure Etudiant
More information7 Initial Ventilator Settings, ~05
Abbreviations (inside front cover and back cover) PART 1 Basic Concepts and Core Knowledge in Mechanical -- -- -- -- 1 Oxygenation and Acid-Base Evaluation, 1 Review 01Arterial Blood Gases, 2 Evaluating
More informationKeeping Patients Off the Vent: Bilevel, HFNC, Neither?
Keeping Patients Off the Vent: Bilevel, HFNC, Neither? Robert Kempainen, MD Pulmonary and Critical Care Medicine Hennepin County Medical Center University of Minnesota School of Medicine Objectives Summarize
More informationMechanical Ventilation ศ.พ.ญ.ส ณ ร ตน คงเสร พงศ ภาคว ชาว ส ญญ ว ทยา คณะแพทยศาสตร ศ ร ราชพยาบาล
Mechanical Ventilation ศ.พ.ญ.ส ณ ร ตน คงเสร พงศ ภาคว ชาว ส ญญ ว ทยา คณะแพทยศาสตร ศ ร ราชพยาบาล Goal of Mechanical Ventilation Mechanical ventilation is any means in which physical device or machines are
More informationNON-INVASIVE VENTILATION. Lijun Ding 23 Jan 2018
NON-INVASIVE VENTILATION Lijun Ding 23 Jan 2018 Learning objectives What is NIV The difference between CPAP and BiPAP The indication of the use of NIV Complication of NIV application Patient monitoring
More informationPreventing Respiratory Complications of Muscular Dystrophy
Preventing Respiratory Complications of Muscular Dystrophy Jonathan D. Finder, MD Professor of Pediatrics University of Pittsburgh School of Medicine Children s Hospital of Pittsburgh Introduction Respiratory
More informationEarly predictors of success of non-invasive positive pressure ventilation in hypercapnic respiratory failure
ORIGINAL ARTICLE Early predictors of success of non-invasive positive pressure ventilation in hypercapnic respiratory failure Col D Bhattacharyya*, Brig BNBM Prasad, SM, VSM, Surg Capt PS Tampi (Retd)
More informationWEANING READINESS & SPONTANEOUS BREATHING TRIAL MONITORING
CLINICAL EVIDENCE GUIDE WEANING READINESS & SPONTANEOUS BREATHING TRIAL MONITORING Weaning readiness and spontaneous breathing trial monitoring protocols can help you make the right weaning decisions at
More informationGE Healthcare. Non Invasive Ventilation (NIV) For the Engström Ventilator. Relief, Relax, Recovery
GE Healthcare Non Invasive Ventilation (NIV) For the Engström Ventilator Relief, Relax, Recovery COPD is currently the fourth leading cause of death in the world, and further increases in the prevalence
More informationRespiratory Management of Facioscapulohumeral Muscular Dystrophy. Nicholas S. Hill, MD Tufts Medical Center Boston, MA
Respiratory Management of Facioscapulohumeral Muscular Dystrophy Nicholas S. Hill, MD Tufts Medical Center Boston, MA Respiratory Involvement in FSHD Very variable time of onset rate of progression Muscles
More informationTitle: The Feasibility of Domiciliary Non-Invasive Mechanical Ventilation due to Chronic Respiratory Failure in Very Elderly Patients
Manuscript type: Original Article DOI: 10.5152/TurkThoracJ.2018.18119 Title: The Feasibility of Domiciliary Non-Invasive Mechanical Ventilation due to Chronic Respiratory Failure in Very Elderly Patients
More informationNeuromuscular diseases (NMDs) include both hereditary and acquired diseases of the peripheral neuromuscular system. They are diseases of the
Neuromuscular diseases (NMDs) include both hereditary and acquired diseases of the peripheral neuromuscular system. They are diseases of the peripheral nerves (neuropathies and anterior horn cell diseases),
More informationA study of non-invasive ventilation in acute respiratory failure
Original Research Article A study of non-invasive ventilation in acute respiratory failure Nilima Manohar Mane 1, Jayant L. Pednekar 2, Sangeeta Pednekar 3* 1 Consultant Physician and Diabetologist, Apollo
More informationMechanical Ventilation in COPD patients
Mechanical Ventilation in COPD patients Θεόδωρος Βασιλακόπουλος Καθηγητής Πνευμονολογίας-Εντατικής Θεραπείας Εθνικό & Καποδιστριακό Πανεπιστήμιο Αθηνών Νοσοκομείο «ο Ευαγγελισμός» Adjunct Professor, McGill
More informationEmergency Medicine High Velocity Nasal Insufflation (Hi-VNI) VAPOTHERM POCKET GUIDE
Emergency Medicine High Velocity Nasal Insufflation (Hi-VNI) VAPOTHERM POCKET GUIDE Indications for Vapotherm High Velocity Nasal Insufflation (Hi-VNI ) administration, the patient should be: Spontaneously
More informationHome Mechanical Ventilation. Anthony Bateman
Home Mechanical Ventilation Anthony Bateman What is Long Term Ventilation? LTV is the provision of respiratory support to individuals with non-acute respiratory failure Progression of expected disease
More informationWeaning from Mechanical Ventilation. Dr Azmin Huda Abdul Rahim
Weaning from Mechanical Ventilation Dr Azmin Huda Abdul Rahim Content Definition Classification Weaning criteria Weaning methods Criteria for extubation Introduction Weaning comprises 40% of the duration
More informationDoes long-term oxygen therapy reduce hospitalisation in hypoxaemic chronic obstructive pulmonary disease?
Eur Respir J 2002; 20: 38 42 DOI: 10.1183/09031936.02.00284202 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2002 European Respiratory Journal ISSN 0903-1936 Does long-term oxygen therapy
More information(To be filled by the treating physician)
CERTIFICATE OF MEDICAL NECESSITY TO BE ISSUED TO CGHS BENEFICIAREIS BEING PRESCRIBED BILEVEL CONTINUOUS POSITIVE AIRWAY PRESSURE (BI-LEVEL CPAP) / BI-LEVEL VENTILATORY SUPPORT SYSTEM Certification Type
More informationAECOPD: Management and Prevention
Neil MacIntyre MD Duke University Medical Center Durham NC Professor P.J. Barnes, MD, National Heart and Lung Institute, London UK Professor Peter J. Barnes, MD National Heart and Lung Institute, London
More informationChronic obstructive pulmonary disease
0 Chronic obstructive pulmonary disease Implementing NICE guidance June 2010 NICE clinical guideline 101 What this presentation covers Background Scope Key priorities for implementation Discussion Find
More informationMND Study Day. Martin Latham CNS Leeds Sleep Service
MND Study Day Martin Latham CNS Leeds Sleep Service Objectives: Identifying individuals at risk. Understand issues related to NIV. Understand issues related to secretion management Improve outcomes. Identifying
More informationDo Not Cite. For Public Comment Period DRAFT MEASURE #3: Evaluation of Pulmonary Status Ordered MUSCULAR DYSTROPHY
MEASURE #3: Evaluation of Pulmonary Status Ordered MUSCULAR DYSTROPHY Measure Description All patients diagnosed with a muscular dystrophy who had a pulmonary status evaluation* ordered. Measure Components
More information